2m 2m 2m 2m 2m 2m 2m
KAIROS PHARMA (KAPA)
NYSE
$0.36+$0.02 (+5.06%)
Price as of Jul 14, 2026 10:09 AM EDT- $7.2MMarket Cap
- -50.68%1-Year Change
- BiotechnologyIndustry
KAIROS PHARMA (KAPA)
$0.36+$0.02 (+5.06%)
KAPA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.34 | ||
Change | -$0.01 (-4.20%) | ||
Open | $0.35 | ||
High | $0.37 | ||
Low | $0.34 | ||
Previous Close | $0.35 | ||
Volume | 91,490 | ||
30-Day Average Volume | 109,285 | ||
1-Week Change | -13.14% | ||
1-Month Change | -23.20% | ||
1-Year Change | -50.68% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 21.4M | ||
Total Assets | $5.7M | ||
Market Cap | $7.2M | ||
Enterprise Value | $3.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.2M | ||
EBIT | $0.00 | ||
EBITDA | $40,000.00 | ||
Net Working Capital | $4.0M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | 89 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | N/A | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue